Brain cancer incidence in the provinces of Zaragoza and Navarre (Spain): Effect of age, period and birth cohort

Journal of the Neurological Sciences

Volumn 164, Issue 1, 1999, Pages 93-99

  Ruiz Tovar, M ^a   Lopez Abente G ^a   Pollan M ^a   Aragones N ^a   Ardanaz, E ^b   Moreo, P ^c   Moreno, C ^c   Vergara, A ^c  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^c Cancer Registry of Zaragoza   (Spain)

Author keywords

Brain; Cancer; Effects; Spain; Tumour

Indexed keywords

AGE; ARTICLE; BRAIN CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; FEMALE; HEALTH CARE ACCESS; HIGH RISK POPULATION; HUMAN; MALE; PRIORITY JOURNAL; SPAIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; BRAIN NEOPLASMS; COHORT EFFECT; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SEX DISTRIBUTION; SEX FACTORS; SOCIOECONOMIC FACTORS; SPAIN;

EID: 0345517226     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00048-9     Document Type: Article

References (59)

1. Fleury A., Menegoz F., Grosclaude P., Daures J.P., Henry-Amar M., Raverdy N., Schaffer P., Poisson M., Delattre J.Y. Descriptive epidemiology of cerebral gliomas in France. Cancer. 79:1997;1195-1202.
2. Bahemuka M., Massey E.W., Schoenberg B.S. International mortality from primary nervous system neoplasms: Distribution and trends. Neuroepidemiology. 2:1983;196-205.
3. Greig N.H., Ries L.G., Yanick R., Rapoport S.I. Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst. 82:1990;1621-1624.
4. Helseth A., Mork S.J. Neoplasms of the central nervous system in Norway. III. Epidemiological characteristics of intracranial gliomas according to histology. APMIS. 97:1989;547-555.
5. Modan B., Wagener D.K., Feldman J.J., Rosenberg H.M., Feinleib M. Increased mortality from brain tumors: A combined outcome of diagnostic technology and change of attitude toward the elderly. Am J Epidemiol. 135:1992;1349-1357.
6. Shugg D., Allen B.J., Blizzard L., Dwyer T., Roder D. Brain cancer incidence, mortality and case survival: Observations from two Australian cancer registries. Int J Cancer. 59:1994;765-770.
7. Boyle P., Maisonneuve P., Saracci R., Muir C.S. Is the increased incidence of primary malignant brain tumors in the elderly real? J Natl Cancer Inst. 82:1990;1594-1596.
8. Ruiz-Tovar M., de Pedro-Cuesta J., Pollán-Santamaría M., López-Abente G. Time-trend analysis of mortality from malignant tumors of the nervous system in Spain, 1952-1986. J Neurolog Sci. 131:1995;15-20.
9. Berrino F., Sant M., Verdecchia A., Capocaccia R., Hakulinen T., Estève J. Survival of cancer patients in Europe. The Eurocare Study. 1995;International Agency for Research on Cancer, Lyon. Sci. publ. no.132.
10. López-Abente G., Pollán-Santamaría M., Escolar A., Errezola M., Abraira V. Atlas de mortalidad por cáncer y otras causas en España, 1978-1992. 1996;Fundación Científica de la Asociación Española Contra el Cáncer, Madrid.
11. Osmond C., Gardner M.J. Age, period and cohort models applied to cancer mortality rates. Stat Med. 1:1982;245-259.
12. Pollán M., López-Abente G., Ardanaz E., Moreo P., Vergara A., Aragonés N. Childhood cancer incidence in Zaragoza and Navarre (Spain): 1973-1987. Eur J Cancer. 33:1997;616-623.
13. Pollán M., López-Abente G., Ruiz-Tovar M., Martínez de Aragón M.V. Childhood and adolescent cancer in Spain: Mortality time trends 1956-1990. Eur J Cancer. 31A:1995;1811-1821.
14. González J., Gorgojo L., Martín J., Villar F. Cáncer en España. 1993;Ministerio de Sanidad y Consumo, Madrid.
15. Parkin D.M., Muir C.S., Whelan S.L., Gao Y.T., Ferlay J., Powell J. Cancer incidence in five continents. IARC Sci. Publ. no. 120. VI:1992;International Agency for Research on Cancer, Lyon.
16. Aickin M., Dunn C.N., Flood T.J. Estimation of population denominators for public health studies at the tract, gender and age-specific level. Am J Public Health. 81:1991;918-920.
17. Breslow N. Extra-Poisson variation in log linear models. Appl Stat. 33:1984;38-44.
18. Bennett S. An extension of Williams' method for overdispersion models. GLIM Newslett. 17:1988;12-18.
19. Holford T.R. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health. 12:1991;425-457.
20. Decarli A., La Vecchia C. Age, period and cohort models: review of knowledge implementation in GLIM. Revista de Statistica Applicata. 20:1987;397-410.
21. Wickramaratne P.J., Weissman M.M., Leaf P.J., Holford T. Age, period, and cohort effects on the risk of major depression: results from five United States communities. J Clin Epidemiol. 42:1989;333-343.
22. Davis F.G., Malinski N., Haenszel W., Chang J., Flannery J., Gershman S., Dibble R., Bigner D.D. Primary brain tumor incidence rates in four United States regions, 1985-1989. Neuroepidemiology. 15:1996;103-112.
23. Garfinkel L., Sarhokan B. Trends in brain cancer tumor mortality and morbidity in the United States. Ann NY Acad Sci. 381:1982;1-5.
24. Ahsan H., Neugut A.I., Bruce J.N. Trends in incidence of primary malignant brain tumors in USA, 1981-1990. Int J Epidemiol. 24:1995;1078-1085.
25. Werner M.H., Phuphanich S., Lyman G.H. The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly. Cancer. 76:1995;1634-1642.
26. The Cancer Registry: Cancer Incidence in Sweden, 1984. 1987;25 Schmidts Boktryckeri, Helsingborg.
27. Levi F., La Vecchia C., Te V.C. Descriptive epidemiology of malignant brain tumors in the Swiss Canton of Vaud. Neuroepidemiology. 9:1990;135-142.
28. Kurland L.T., Schoenberg B.S., Annegers J.F., Okazaki H., Molgaard C.A. The incidence of primary intracranial neoplasms in Rochester, Minnesota, 1935-1977. Ann NY Acad Sci. 381:1982;6-16.
29. Tola M.R., Casetta Y., Granieri E., Pinna L., Veronesi V., Tamarozzi R., Trapella G., Monetti V.C., Paolino E., Govoni V., et al. Intracranial gliomas in Ferrara, Italy, 1976-1991. Acta Neurol Scand. 90:1994;312-317.
30. Preston-Martin S. Epidemiology of primary CNS neoplasms. Neurol Clin. 14:1996;273-290.
31. Desmeules M., Mikkelsen T., Mao Y. Increasing incidence of malignant brain tumors: influence of diagnostic methods. J Natl Cancer Inst. 84:1992;442-445.
32. Radhakrishnan K., Mokri B., Parisi J.E., O'Fallon W.M., Sunku J., Kurland L.T. The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Ann Neurol. 37:1995;67-73.
33. Helseth A. The incidence of primary central nervous system neoplasms before and after computerised tomography availability. J Neurosurg. 83:1995;999-1003.
34. Polednak A.P. Interpretation of secular increases in incidence rates for primary brain cancer in Connecticut adults, 1965-1998. Neuroepidemiology. 15:1996;51-56.
35. Polednak A.P. Increased mortality from brain tumors: a combined outcome of diagnostic technology and change of attitude toward the elderly. Am J Epidemiol. 140:1994;1238-1243.
36. Preston-Martin S., Lewis S., Winkelmann R., Borman B., Auld J., Pearce N. Descriptive epidemiology of primary cancer of the brain, cranial nerves, and cranial meninges in New Zealand, 1948-88. Cancer Causes Control. 4:1993;529-538.
37. Demers P.A., Vaughan T.L., Schommer R.R. Occupation, socioeconomic status, and brain tumor mortality: a death certificate-based case-control study. J Occup Med. 33:1991;1001-1006.
38. Orfeuvre H., Lutz J.M., Menegoz F., Exbrayat C., Colonna M., Schaerer R. Incidents of brain tumors observed in the Grenoble area (canton of Meylan) 1979-1990. Rev Neurol Paris. 149:1993;340-344.
39. Eaton N., Shaddick G., Elliott P. Small-area study of the incidence of neoplasms of the brain and central nervous system among adults in the West Midlands Region, 1974-86. Br J Cancer. 75:1997;1080-1083.
40. Anuario 1996. 1996;Ediciones El País, Madrid.
41. Anuario del Mercado Español 1991. 1991;Banco Español de Crédito, Madrid.
42. Muir C.S., Nectoux J. International patterns of cancer. Schottenfeld D., Fraumeni J.F. Cancer Epidemiology and Prevention. 1996;Oxford University Press, New York.
43. Levi F., Maisonneuve P., Filiberti R., La Vecchia C., Boyle P. Cancer incidence and mortality in Europe. Soz. Praeventivmed. 34:(Suppl 2):1989;50.
44. López-Abente Ortega G. Cáncer en agricultores. Mortalidad proporcional y estudios caso-control con certificados de defunción. 1991;Fondo de Investigación Sanitaria, Madrid.
45. Rodvall Y., Ahlbom A., Spannare B., Nise G. Glioma and occupational exposure in Sweden: a case-control study. Occup Environ Med. 53:1996;526-537.
46. Smith-Rooker J.L., Garret A., Hodges L.C., Shue V. Prevalence of glioblastoma multiforme subjects with prior herbicide exposure. J Neurosci Nurs. 24:1992;260-264.
47. Heineman E.F., Gao Y.T., Dosemeci M., McLaughlin J.K. Occupational risk factors for brain tumors among women in Shanghai, China. J Occup Environ Med. 37:1995;288-293.
48. Censo Agrario. 1982;INE, Madrid.
49. Teta M.J., Ott M.G., Schnatter A.R. An update of mortality due to brain neoplasms and other causes among employees of a petrochemical facility. J Occup Med. 33:1991;45-51.
50. Waxweiler R.J., Alexander V., Leffingwell S.S., Haring M., Lloyd J.W. Mortality from brain tumor and other causes in a cohort of petrochemical workers. J Natl Cancer Inst. 70:1983;75-81.
51. Anttila A., Pukkala E., Sallmen M., Hernberg S., Hemminki K. Cancer incidence among Finnish workers exposed to halogenated hydrocarbons. J Occup Environ Med. 37:1995;797-806.
52. Sorahan T., Parkes H.G., Veys C.A. Mortality in the British rubber industry, 1946-85. Br J Ind Med. 46:1989;1-11.
53. Preston-Martin S., Mack W., Henderson B.E. Risk factors for gliomas and meningiomas in males in Los Angeles County. Cancer Res. 49:1989;6137-6143.
54. Monson R.R., Fine L.J. Cancer mortality and morbidity among rubber workers. J Natl Cancer Inst. 61:1978;1047-1053.
55. Guenel P., Nicolau J., Imbernon E., Chevalier A., Goldberg M. Exposure to 50-Hz electric field and incidence of leukemia, brain tumors, and other cancers among French electric utility workers. Am J Epidemiol. 144:1996;1107-1121.
56. Theriault G., Goldberg M., Miller A.B., Armstrong B., Guenel P., Deadman J., Imbernon E., To T., Chevalier A., Cyr D., et al. Cancer risks associated with occupational exposure to magnetic fields among electric utility workers in Ontario and Quebec, Canada, and France: 1970-1989. Am J Epidemiol. 139:1994;550-572.
57. Li C.Y., Theriault G., Lin R.S. Residential exposure to 60-Hertz magnetic fields and adult cancers in Taiwan. Epidemiology. 8:1997;25-30.
58. Tynes T., Haldorsen T. Electromagnetic fields and cancer in children residing near Norwegian high-voltage power lines. Am J Epidemiol. 145:1997;219-226.
59. Harrington J.M., McBride D.I., Sorahan T., Paddle G.M., van Tongeren M. Occupational exposure to magnetic fields in relation to mortality from brain cancer among electricity generation and transmission workers. Occup Environ Med. 54:1997;7-13.